Drugs Made In America Acquisition (DMAA) Stock Chart & Stock Price History $10.26 -0.01 (-0.10%) As of 03:57 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsOwnershipSEC FilingsShort InterestTrendsBuy This Stock Drugs Made In America Acquisition Stock Price Performance The Drugs Made In America Acquisition (DMAA) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has increased 0.10%, reflecting recent market activity. As of the latest close, Drugs Made In America Acquisition traded at $10.27 with a market cap of $299.59 million and volume of 5,057 shares. Receive DMAA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Drugs Made In America Acquisition and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-0.19%1 Month Performance+0.10% DMAA Stock Chart for Wednesday, October, 1, 2025 DMAA Chart by TradingView Drugs Made In America Acquisition Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/01/2025$10.27$10.26-0.10%$10.27$10.265,033 shs$299.28 million09/30/2025$10.27$10.27$10.28$10.265,057 shs$299.59 million09/29/2025$10.28$10.27-0.10%$10.28$10.2684,201 shs$299.58 million09/26/2025$10.28$10.28$10.28$10.264,515 shs$299.87 million09/25/2025$10.31$10.28-0.29%$10.30$10.26159,001 shs$299.87 million09/24/2025$10.26$10.31+0.49%$10.34$10.28545,562 shs$300.75 million09/23/2025$10.30$10.26-0.39%$10.27$10.26211 shs$299.28 million09/22/2025$10.28$10.30+0.19%$10.30$10.26864 shs$300.45 million09/19/2025$10.28$10.28$10.28$10.262,207 shs$299.87 million09/18/2025$10.27$10.28+0.10%$10.28$10.262,207 shs$299.88 million Get the Latest News and Ratings for DMAA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Drugs Made In America Acquisition and its competitors with MarketBeat's FREE daily newsletter. 09/17/2025$10.27$10.27$10.28$10.2661,187 shs$299.58 million09/16/2025$10.26$10.27+0.10%$10.30$10.27395 shs$299.58 million09/15/2025$10.30$10.26-0.39%$10.27$10.2347,956 shs$299.29 million09/12/2025$10.25$10.30+0.49%$10.30$10.252,791 shs$300.46 million09/11/2025$10.28$10.25-0.29%$10.27$10.2544,800 shs$298.99 million09/10/2025$10.30$10.28-0.19%$10.28$10.253,384 shs$299.87 million09/09/2025$10.29$10.30+0.10%$10.30$10.26682 shs$300.46 million09/08/2025$10.26$10.29+0.29%$10.29$10.26650 shs$300.16 million09/05/2025$10.26$10.26$10.26$10.264,781 shs$299.28 million09/04/2025$10.29$10.26-0.29%$10.27$10.264,449 shs$299.28 million09/03/2025$10.26$10.29+0.29%$10.29$10.29101 shs$300.17 million09/02/2025$10.25$10.26+0.10%$10.28$10.252,810 shs$299.28 million09/01/2025$10.25$10.25$10.25$10.251,023 shs$298.99 million Related Companies BRDG Stock Price Chart SBR Stock Price Chart SAFE Stock Price Chart DEA Stock Price Chart ORC Stock Price Chart PAX Stock Price Chart PLYM Stock Price Chart CSR Stock Price Chart UNIT Stock Price Chart FBRT Stock Price Chart Receive DMAA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Drugs Made In America Acquisition and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DMAA) was last updated on 10/1/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredTrump’s “Smart Dollar” just went mainstream"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredTrump is Fast-Tracking These Three CompaniesThe Trump administration is planning to invest DIRECTLY in a small sector of the stock market… And they just r...InvestorPlace | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Drugs Made In America Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Drugs Made In America Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DMAA Stock Alerts